Related Experiment Video
Updated: Sep 20, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
No association of germline alteration of MSR1 with prostate cancer risk
Liang Wang1, Shannon K McDonnell, Julie M Cunningham
1Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, 920 Hilton Building, Mayo Clinic and Foundation, Rochester, Minnesota, USA.
Abstract:
The macrophage scavenger receptor 1 gene (MSR1) was recently identified as a candidate susceptibility gene for hereditary prostate cancer and as a risk factor for sporadic prostate cancer. To confirm these findings, we screened MSR1 for germline mutations among individuals with familial prostate cancer and tested gene variants for associations in both sporadic and familial prostate cancer. Our results do not support MSR1 as a risk factor for prostate cancer.
Insights
The macrophage scavenger receptor 1 (MSR1) gene was investigated for its role in prostate cancer risk. Genetic screening and association tests found no evidence that MSR1 mutations contribute to hereditary or sporadic prostate cancer.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The macrophage scavenger receptor 1 gene (MSR1) has been proposed as a potential susceptibility gene for hereditary prostate cancer and a risk factor for sporadic forms.
- Previous studies suggested a possible link between MSR1 and prostate cancer development, necessitating further investigation.
Purpose of the Study:
- To rigorously evaluate the role of the MSR1 gene in the etiology of prostate cancer.
- To screen for germline mutations in MSR1 within families affected by prostate cancer.
- To assess the association of MSR1 gene variants with both familial and sporadic prostate cancer.
Main Methods:
- Germline DNA was screened for mutations in the MSR1 gene in individuals with a history of familial prostate cancer.
- Gene variants within MSR1 were tested for statistical association with prostate cancer risk in both familial and sporadic cohorts.
- Comprehensive genetic analysis was employed to examine the MSR1 gene's contribution.
Main Results:
- Screening of the MSR1 gene did not reveal significant germline mutations in individuals with familial prostate cancer.
- Association analyses of MSR1 gene variants did not demonstrate a statistically significant link to increased risk for either familial or sporadic prostate cancer.
- The findings indicate a lack of correlation between MSR1 and prostate cancer susceptibility.
Conclusions:
- The study's results do not support the hypothesis that MSR1 is a significant risk factor or susceptibility gene for prostate cancer.
- Further research may be needed to explore other genetic factors influencing prostate cancer development.
- The MSR1 gene's role in prostate cancer appears to be minimal based on current evidence.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
The Ras Gene
Ras is a superfamily...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation